NEWS

Roche Translational Neuroscience Symposium

RTNS 2012

Better tools needed to assess clinical trials

by  /  14 May 2012
The past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.
RTNS 2012

Trials and tribulations

by  /  11 May 2012
Clinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.
RTNS 2012

Compensatory mechanisms

by  /  8 May 2012
Identifying genetic and other factors that protect children at risk of autism from developing the disorder could provide new avenues for treatment.
May 2012
RTNS 2012

Debate over quality of adult-derived stem cells rages on

by  /  7 May 2012

As the use of induced pluripotent stem cells grows, researchers are searching for ways to make them behave more predictably. 

0 Comments
RTNS 2012

Complex case

by  /  4 May 2012

Multiple levels of complexity make it challenging to develop drugs to treat autism.

0 Comments
April 2012
RTNS 2012

Fast-forward

by  /  27 April 2012

In the last three years, autism researchers have gone from sequencing single genes to whole exomes, as highlighted at the Translational Neuroscience Symposium in Switzerland last week.

0 Comments